GlassScriptPhysician profile
Marc A Abboud
NPI 1265096531
$5,130.62
in general payments reported to CMS, 2019-2025
27 companies · $1,757 in 2025
The $1,757 reported for 2025 was more than what 77% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $507 · 2024: $2,867 · 2025: $1,757.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,316 · Travel and Lodging: $1,598 · Education: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,315.84 |
| Travel and Lodging | $1,598.48 |
| Education | $216.30 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,524.87 | 2023-2025 | Rezum Generator, Tactra, Ams 700 Cxr Rte Kit |
| Urogen Pharma, INC. | $349.70 | 2025 | |
| Valencia Technologies Corporation | $310.38 | 2025 | Ecoin Device Kit |
| Astellas Pharma US INC | $243.27 | 2024-2025 | |
| Coloplast Corp | $235.36 | 2023-2024 | Titan |
| Endo USA, INC. | $228.93 | 2024-2025 | Xiaflex, Aveed |
| Agiliti Surgical, INC. | $150.68 | 2025 | Koelis Trinity Mri/US Fusion, Sonablate Hifu |
| Laborie Medical Technologies Corp. | $143.82 | 2024 | Optilume Bph Drug Coated Balloon Catheter |
| Ambu INC. | $118.21 | 2024 | |
| Immunitybio, INC. | $98.77 | 2024-2025 | |
| Abbvie INC. | $83.15 | 2024-2025 | |
| Sumitomo Pharma America, INC. | $79.71 | 2025 | Gemtesa |
| Endo Pharmaceuticals INC. | $76.09 | 2024 | Xiaflex |
| Accord Healthcare, INC. | $70.58 | 2024-2025 | |
| C. R. Bard, INC. & Subsidiaries | $63.93 | 2025 | Bard Urinary Drainage Bag |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $59.33 | 2025 | Erleada |
| Teleflex LLC | $59.24 | 2024-2025 | Urolift |
| Tolmar, INC. | $44.41 | 2024-2025 | Eligard |
| Novartis Pharmaceuticals Corporation | $29.00 | 2025 | |
| Procept Biorobotics Corporation | $28.24 | 2025 | |
| Progenics Pharmaceuticals, INC. | $23.60 | 2024 | |
| Novo Nordisk INC | $21.08 | 2024 | |
| Myriad Genetic Laboratories, INC. | $19.62 | 2024 | Prolaris |
| Pfizer INC. | $18.99 | 2025 | |
| Sagent Pharmaceuticals | $17.07 | 2025 | Glydo |
| Becton, Dickinson and Company | $16.74 | 2024 | Bard Urinary Drainage Bag |
| Dentsply Ih Ab | $15.85 | 2025 | Lofric |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marc Abboud listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.